Aktuella utlysningar, vecka 47, 2017

Publicerat 2017-11-20 10:18. Uppdaterat 2017-11-21 15:49

Grants Office tipsar om aktuella utlysningar

Swedish and Nordic Grants 

Swedish Urology Nurses Specialist Society | Riksföreningen för Sjuksköterskor inom Urologi

Medac stipendium inom urologi syftar till att stimulera sjuksköterskor till utveckling av vården för patienter med diagnosen urinblåsecancer. Stipendiet omfattar SEK 15,000 och kan användas till resor för utvecklings- och forskningsarbeten samt kurser, utbildningar och hospiteringar. 

Closing date: 31 Dec 2017

Swedish Urology Nurses Specialist Society | Riksföreningen för Sjuksköterskor inom Urologi

Märta Lundqvist Foundation | Märta Lundqvists Stiftelse

Stöder medicinsk forskning vid svenska universitet som är relaterad till den mänskliga hjärnans område. 

Closing date: 9 Jan 2018

Märta Lundqvist Foundation | Märta Lundqvists Stiftelse 

Kostfonden

Anslår medel till en eller flera högkvalitativa interventionsstudier som på ett strukturerat vis utreder hur fetma, insulinresistens, typ 2-diabetes eller problem/sjukdomar relaterade till dessa, kan förebyggas eller behandlas med kostens hjälp.

Closing date: 15 Jan 2018

Kostfonden

Sixten Gemzéus studiestipendier för högre utlandsstudier Gålöstiftelsen

Dessa främjar självständiga teoretiska eller praktiska studier i första hand utanför Sverige. 

Closing date: 15 Jan 2018

Sixten Gemzéus studiestipendier för högre utlandsstudier Gålöstiftelsen

Start-up grants for paediatric oncology Swedish Childhood Cancer Foundation | Barncancerfonden

Aim to create research group collaborations and consortia and provide funding to apply for larger grants, such as EU-grants. The grants cover costs for start-up meetings, travel costs and other possible costs associated with the application procedure. In exceptional cases, salary costs for writing applications may be granted.  

Closing date: 15 Jan 2018

Start-up grants for paediatric oncology Swedish Childhood Cancer Foundation | Barncancerfonden 

Vinnova - Projekt för bättre hälsa

Detta främjar projekt med stor innovationspotential som kan bidra till förbättrad prevention, diagnos, monitorering eller behandling av sjukdomar och andra tillstånd som kräver sjukvård. Stöd uppgår till max 50 procent av de stödberättigande kostnaderna för projektet, dock maximalt SEK 1 miljon per projekt. 

Closing date: 25 Jan 2018

Vinnova - Projekt för bättre hälsa 

Resestipendier för doktorander inom preklinisk och klinisk medicinsk forskning - Svenska Sällskapet för medicinsk forskning

Behöriga att söka dessa stipendier är registrerade doktorander med minst en egen refereegranskad publikation. Stipendierna delas ej ut till disputerade forskare eller doktorander som inte är registrerade. Resan får påbörjas tidigast 1 månad efter ansökningstidens utgång.
Till vad och hur länge?
Stipendierna är avsedda att täcka extraordinära personliga kostnader i samband med resa till annan forskningsinstitution eller klinik för studier av betydelse för sökandens eget forskningsprojekt. Stipendier ges till resor för att lära sig ny metodik eller samla in forskningsdata eller andra likartade ändamål. Personlig inbjudan från värdinstitution samt intyg från huvudhandledare skall bifogas. Stipendiet beviljas högst 3 gånger. Stipendium utdelas ej för kurser, konferenser- eller kongressresor, för material,tryckning eller andra driftskostnader. Ej heller godkännes traktamente eller ersättning för matkostnader under perioden.
Ansökningsperiod
Ansökan sker elektroniskt och kan sökas 4 gånger per år, 1 mars, 1 juni, 1 sept och 1 dec.

Resestipendier för doktorander inom preklinisk och klinisk medicinsk forskning - Svenska Sällskapet för medicinsk forskning

European grants

Pre-announcement of the sixth Call

Full call for Proposals will  be published January 2018

Aims:

Control of AMR needs actions addressing issues at human, animal and environmental levels, according to an approach usually referred to as “One Health”. Following publication of the WHO Global priority list of antibiotic-resistant bacteria (including Mycobacterium tuberculosis multi-and extensively drug resistant)[1], the JPIAMR is launching a joint transnational call with the aim to discover new targets, compounds and tools with the potential to help controlling diseases caused by resistant bacteria from the above-mentioned WHO pathogen list in human, animal or environmental settings.

Closing date: March 2018

Pre-announcement of the sixth Call

JSPS Fellowships - For research in Japan

JSPS Headquarters offer several fellowship programs to give opportunities for excellent researchers from around the world to conduct scientific collaboration in Japan with their Japanese colleagues.

JSPS Stockholm Office and Nordic/Baltic nominating authorities support researchers who wish to go to Japan through these programs.

Closing date: 8/28 Feb 2018

JSPS Fellowships - For research in Japan

Research grants - Jérôme Lejeune Foundation

The Jérôme Lejeune Foundation invites applications for its research grants. These support research on down syndrome or other intellectual disabilities of genetic origin appearing in early childhood. Projects may aim to decipher the pathophysiology of the cognitive deficits of patients, especially those with trisomy 21 and linked pathologies as well as knowledge of the chromosome 21. Project may also be related to such rare abnormalities as fragile X, cri du chat, Rett, Williams-Beuren, Prader-Willi and Angelman and other syndromes. Priority is given to clinical research projects. Every type of research can be considered, from molecular biology to clinical pharmacology to neuropsychology.

Closing date: 5 March 2018

Research grants - Jérôme Lejeune Foundation

Research grants - Tom Wahlig Foundation

The Tom Wahlig Foundation invites applications for its research grants. These support research into, or with conceptual connections to, the hereditary spastic paraplegias. Topics to be covered may be clinical, genetic or functional in nature, and projects may represent

self-contained small studies or be intended to generate preliminary data that enable alternative subsequent funding for a larger follow-up study.

Closing date: 15 Dec 2017

Research grants - Tom Wahlig Foundation

Pre-announcement - 2018 Joint Transnational Call for Research Proposals

The EU Joint Programme for Neurodegenerative Disease Research invites applications for its call for multinational research projects on health and social care for neurodegenerative diseases. This supports multidisciplinary projects which focus on health and social care for Alzheimer and other neurodegenerative diseases. 

Closing date: March 2018

Pre-announcement - 2018 Joint Transnational Call for Research Proposals

US grants

Federal Funding agencies

Prescription drug abuse (R01): NIH

The purpose of this funding opportunity is to develop innovative research on prescription drug abuse, including research to examine the factors contributing to prescription drug abuse; to characterise the adverse medical, mental health and social consequences associated with prescription drug abuse; and to develop effective prevention and service delivery approaches and behavioural and pharmacological treatments. Studies on individual- and patient-level factors, prescriber factors, and health system factors are encouraged, as are studies on all classes of prescription drugs with high abuse liability, including analgesics, stimulants, sedative or hypnotics and anxiolytics.

Closing dates: applications due by 5pm local time of applicant organisation every 5 February, (5 June and 5 October until 8 May 2019).

Funding Opportunity Announcement (FOA): PA-18-058

Nutrition and alcohol-related health outcomes (R01): NIH

The purpose of this funding opportunity is to encourage applications that examine associations between nutrition and alcohol-related health outcomes in humans and in animal models. The goal is to stimulate a broad range of research on the role of nutrition in the development, prevention, and treatment of a variety of alcohol-related health outcomes including alcohol dependence and psychiatric co-morbidities, chronic and acute diseases, and organ function and damage. Study designs may include experimental studies, feeding studies, epidemiologic approaches, and prevention/intervention studies.

Closing dates: applications due by 5pm local time of applicant organisation every 5 February, (5 June and 5 October until 8 May 2020).

Funding Opportunity Announcement (FOA): PA-17-211

Research on autism spectrum disorders (R01): NIH

The purpose of this funding opportunity is to encourage research grant applications to support research designed to elucidate the etiology, epidemiology, diagnosis, treatment, and optimal means of service delivery in relation to Autism Spectrum Disorders (ASD). 

Closing dates: applications due by 5pm local time of applicant organisation every 5 Feb, (5 June and 5 Oct until 8 Sept 2019).

Funding Opportunity Announcement (FOA): PA-16-388

Foundations

Clinical trials in thalassaemia cell and gene therapy grant - Cooley’s Anemia Foundation

The Cooley’s Anemia Foundation invites national and international applicants to apply for grants to facilitate clinical trials in Cell and Gene Therapy to advance a cure for thalassemia. Both phase I (safety) and phase II (efficacy) trials are eligible for support.

Closing date: The application is due 5 Feb 2018.

Clinical trials in thalassaemia cell and gene therapy grant - Cooley’s Anemia Foundation 

Research grants - Hereditary Disease Foundation

The Hereditary Disease Foundation provides funding for research that advances the discovery and development of treatments for Huntington’s disease (HD) and other brain disorders. The Foundation’s current focus is on 1) modifier studies - on DNA repair pathways, protein degradation and other modifiers of phenotype and age of onset and 2) research mechanisms of HD neurodegeneration and biomarkers and therapy for HD-induced neurodegeneration.

Closing dates: Letters of intent due by 1 Feb 2017; applications due by 15 April 2017.

Research grants - Hereditary Disease Foundation 

Länkar